Variable | Number of Recurrence | One year disease free survival | Three years disease free survival | Five years disease free survival | Mean disease free survival | P Value | |
---|---|---|---|---|---|---|---|
Mean (month) ± Se | |||||||
Stage | Early | 10 | 95,30% | 91,30% | 85,70% | 85,076 ± 2,94 | < 0,001 |
Advanced | 98 | 78,30% | 32,50% | 18,80% | 33,167 ± 2,79 | ||
Grade | Well (1) | 12 | 94,20% | 85,70% | 78,90% | 80,32 ± 3,82 | P (1–2) < 0,001 |
Moderate (2) | 49 | 79,20% | 47,40% | 30,00% | 42,25 ± 3,84 | P (2–3) =0,384 | |
Poor (3) | 47 | 82,40% | 35,70% | 28,50% | 38,86 ± 4,18 | P (1–3) < 0,001 | |
PLT | ≤400 | 71 | 89,30% | 62,60% | 51,60% | 59,89 ± 3,09 | < 0,001 |
> 400 | 37 | 70,40% | 30,40% | 24,30% | 33,54 ± 4,33 | ||
PLR | ≤231 | 66 | 88,60% | 64,40% | 55,20% | 61,42 ± 3,13 | < 0,001 |
> 231 | 42 | 73,20% | 28,80% | 18,70% | 33,75 ± 4,38 | ||
NLR | ≤3,83 | 65 | 89,30% | 62,70% | 54,50% | 60,4 ± 3,22 | < 0,001 |
> 3,83 | 43 | 73,40% | 37,30% | 27,60% | 39,1 ± 4,52 | ||
General | 108 | 34–84,8% | 93–55,3% | 106–45,5% | 54,21 ± 2,73 | – |